Effect of first-line endocrine therapy in patients with hormone-sensitive advanced breast cancer: a network meta-analysis [Corrigendum]
Zhang T, Feng F, Zhao W, et al. Onco Targets Ther. 2018;11:2647–2656. On page 2647, affiliation list, affiliation 1 for authors Tingting Zhang and Chuanxin Zang should be: College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan,...
Main Authors: | Zhang T, Feng F, Zhao W, Tian J, Yao Y, Zhou C, Dong S, Wang C, Zang C, Lv Q, Sun C |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-07-01
|
Series: | OncoTargets and Therapy |
Online Access: | https://www.dovepress.com/corrigendumeffect-of-first-line-endocrine-therapy-in-patients-wit-peer-reviewed-article-OTT |
Similar Items
-
Effect of first-line endocrine therapy in patients with hormone-sensitive advanced breast cancer: a network meta-analysis
by: Zhang T, et al.
Published: (2018-05-01) -
The renaissance of endocrine therapy in hormone sensitive breast cancer
by: article Editorial
Published: (2019-12-01) -
Comparative efficacy of different targeted therapies plus fulvestrant for advanced breast cancer following progression on prior endocrine therapy: a network meta-analysis
by: Zhang T, et al.
Published: (2018-11-01) -
Maintenance hormone therapy with Letrozole after first-line chemotherapy for advanced breast cancer.
by: Bertelli, Gianfilippo, et al.
Published: (2005) -
Combined endocrine approaches vs endocrine therapy alone as first line treatment in elderly patients with hormone receptor-positive, HER2 negative, advanced breast cancer: to prescribe for the patient or the physician? A meta-analysis of phase II and III randomized clinical trials
by: Claudia Omarini, et al.
Published: (2020-05-01)